Related Experiment Videos
Cardiac autonomic dysfunction in diabetic children
M M Massin1, B Derkenne, M Tallsund
1Division of Pediatric Cardiology, University of Liège, Belgium. martial.massin@chrcitadelle.be
Diabetes Care
|November 5, 1999
Summary
Heart rate variability (HRV) analysis can detect early cardiac autonomic neuropathy in children with type 1 diabetes, especially around puberty. Screening is recommended at puberty
Area of Science:
- Pediatric Endocrinology
- Cardiology
- Diabetology
Background:
- Type 1 diabetes can lead to cardiac autonomic neuropathy, affecting heart rate variability (HRV) in adults.
- Subclinical autonomic dysfunction may be present in diabetic children, impacting cardiovascular health.
- Early detection of neuropathy is crucial for managing long-term complications in pediatric diabetes.
Purpose of the Study:
- To investigate the utility of HRV analysis in detecting subclinical cardiac autonomic neuropathy in children with type 1 diabetes.
- To determine if HRV indices correlate with established risk factors for diabetic complications in pediatric populations.
Main Methods:
- Prospective study involving 73 children and adolescents (3-18 years) with type 1 diabetes.
- Analysis of 24-hour Holter recordings to assess time and frequency domain HRV indices.
- Comparison of HRV measures with normal ranges and correlation with metabolic control, illness duration, and microalbuminuria.
Main Results:
- HRV indices were significantly reduced in diabetic children aged 11 years and older.
- HRV abnormalities correlated with long-term metabolic control (4-year mean GHb) in older children.
- Illness duration and microalbuminuria independently predicted HRV abnormalities, while recent metabolic control did not.
Conclusions:
- Early puberty is a critical period for developing diabetic cardiac autonomic dysfunction.
- HRV analysis is a valuable tool for screening type 1 diabetic patients for autonomic neuropathy starting at puberty.
- Screening should be implemented regardless of illness duration, microalbuminuria, or current metabolic control levels.